DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Bethesda North Marriott Hotel and Conference Center

2026年10月19日 (月) 午前 7:00 - 2026年10月20日 (火) 午後 5:00

5701 Marinelli Road, North Bethesda, MD 20852

Real-World Evidence Conference

Translating Insights into Real-World Value

Case Study (Non- CE) Hosted By Curavit: Build Regulatory-Grade by Deploying Prospective Linkage and Virtual Sites to Satisfy FDA Standards

Session Chair(s)

Dave  Hanaman

Dave Hanaman

President & Co-Founder, Curavit, United States

Retrospective real-world evidence often fails regulatory scrutiny due to data gaps, selection bias, and unresolvable data provenance. To overcome these structural limitations, life sciences organizations must shift to prospective, execution-driven evidence generation. This session presents an integrated blueprint combining virtual clinical sites, instant eligibility screening, and patient-authorized record linkage to capture audit-ready data continuously across multi-year horizons. Attendees will explore real-world case examples demonstrating how to generate defensible, regulatory-grade RWE that satisfies FDA mandates while accelerating trial timelines.

Learning Objective : At the conclusion of this session attendees should be able to:
  • Identify and overcome core flaws in traditional retrospective RWE, including missing data and selection bias
  • Apply a framework combining decentralized execution, tokenized record linkage, and analytics to meet FDA standards
  • Evaluate real-world implementations of automated screening and patient linkage to power External Control Arms

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。